A single-center retrospective study of anlotinib in metastatic renal cell carcinoma
Latest Information Update: 15 Oct 2021
At a glance
- Drugs Catequentinib (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 15 Oct 2021 New trial record